Fluorescent Nanosystems for Drug Tracking and Theranostics: Recent Applications in the Ocular Field

Abstract

The greatest challenge associated with topical drug delivery for the treatment of diseases affecting the posterior segment of the eye is to overcome the poor bioavailability of the carried molecules. Nanomedicine offers the possibility to overcome obstacles related to physiological mechanisms and ocular barriers by exploiting different ocular routes. Functionalization of nanosystems by fluorescent probes could be a useful strategy to understand the pathway taken by nanocarriers into the ocular globe and to improve the desired targeting accuracy. The application of fluorescence to decorate nanocarrier surfaces or the encapsulation of fluorophore molecules makes the nanosystems a light probe useful in the landscape of diagnostics and theranostics. In this review, a state of the art on ocular routes of administration is reported, with a focus on pathways undertaken after topical application. Numerous studies are reported in the first section, confirming that the use of fluorescent within nanoparticles is already spread for tracking and biodistribution studies. The first section presents fluorescent molecules used for tracking nanosystems’ cellular internalization and permeation of ocular tissues; discussions on the classification of nanosystems according to their nature (lipid-based, polymer-based, metallic-based and protein-based) follows. The following sections are dedicated to diagnostic and theranostic uses, respectively, which represent an innovation in the ocular field obtained by combining dual goals in a single administration system. For its great potential, this application of fluorescent nanoparticles would experience a great development in the near future. Finally, a brief overview is dedicated to the use of fluorescent markers in clinical trials and the market in the ocular field.

Green Synthesis of Hexagonal Silver Nanoparticles Using a Novel Microalgae Coelastrella aeroterrestrica Strain BA_Chlo4 and Resulting Anticancer, Antibacterial, and Antioxidant Activities

“…These nanostructures substantially impact global morbidity and mortality [ 1 , 2 ]. Many nanosystems have been approved by the Food and Drug Administration (FDA) as chemotherapeutics, bioimaging tools, and nutritional supplements [ 3 , 4 ]. There are three main methods for fabricating nanoparticles (NPs), including physical, chemical, and biological approaches [ 5 , 6 ].…”

Multifunctional Layered Double Hydroxides for Drug Delivery and Imaging

“…Although in-vivo fluorescence imaging has a limited penetration depth, fluorescent nanosystems for drug monitoring are being developed in the ocular field [ 124 ]. According to a study of flurbiprofen (FB) for ocular delivery as a non-steroidal anti-inflammatory drug, a hyaluronic acid (HA)-coated FB intercalated-LDH ophthalmic DDS (HA-FB-LDH) [ 125 ] has been designed.…”

Fluorescent Probes as a Tool in Diagnostic and Drug Delivery Systems

“…The recent advances in the design and synthesis of fluorescent probes for diagnostic purposes and monitoring in drug delivery systems are discussed in several reviews [ 31 , 32 , 33 , 34 , 35 ]. Generally, they have been studied from a diagnostic point of view or described as complex nanoparticles.…”